David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WIN
2351
DELISTED
Windstream Holdings Inc
WIN
| $1.59M | ﹤0.01% |
302,353
+146,801
| +94% | +$1.03M |
|
2352
Aptevo Therapeutics
APVO
$4.43M
| – | – |
0
| – | – |
|
2353
PUT
Kimberly-Clark
KMB
$36.9B
| $1.58M | ﹤0.01% |
+15,000
| New | +$1.56M |
|
2354
Prestige Consumer Healthcare
PBH
$2.44B
| $1.58M | ﹤0.01% |
+41,085
| New | +$1.39M |
|
2355
CALL
Johnson Controls International
JCI
$85.9B
| $1.57M | ﹤0.01% |
+47,000
| New | +$1.63M |
|
2356
Columbia Banking Systems
COLB
$8.64B
| $1.57M | ﹤0.01% |
38,382
-36,298
| -49% | -$1.55M |
|
|
HMHC
2357
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $1.57M | ﹤0.01% |
205,222
+16,134
| +9% | +$115K |
|
2358
BioMarin Pharmaceuticals
BMRN
$12.8B
| $1.57M | ﹤0.01% |
16,644
-69,066
| -81% | -$6.05M |
|
|
KE
2359
Kimball Electronics
KE
$565M
| $1.57M | ﹤0.01% |
85,553
+10,017
| +13% | +$179K |
|
2360
Toyota
TM
$228B
| $1.56M | ﹤0.01% |
12,145
-6,753
| -36% | -$890K |
|
|
PE
2361
PUT
DELISTED
PARSLEY ENERGY INC
PE
| $1.56M | ﹤0.01% |
51,500
| – | – |
|
2362
Lennar Class B
LEN.B
$20.7B
| $1.56M | ﹤0.01% |
38,403
+4,253
| +12% | +$176K |
|
2363
Alliant Energy
LNT
$17.7B
| $1.55M | ﹤0.01% |
+36,648
| New | +$1.51M |
|
2364
PUT
GameStop
GME
$8.12B
| $1.55M | ﹤0.01% |
425,600
-49,200
| -10% | -$169K |
|
2365
Arrowhead Research
ARWR
$12.6B
| $1.55M | ﹤0.01% |
113,909
-777,875
| -87% | -$7.27M |
|
2366
Hamilton Lane
HLNE
$4.63B
| $1.55M | ﹤0.01% |
32,295
+17,643
| +120% | +$776K |
|
|
SCHW
2367
CALL
Charles Schwab
SCHW
$194B
| $1.55M | ﹤0.01% |
+30,300
| New | +$1.68M |
|
2368
Watts Water Technologies
WTS
$12.4B
| $1.55M | ﹤0.01% |
19,738
+7,013
| +55% | +$544K |
|
|
OXFD
2369
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.55M | ﹤0.01% |
120,058
+95,222
| +383% | +$1.29M |
|
2370
PUT
Fabrinet
FN
$15.5B
| $1.55M | ﹤0.01% |
41,900
-6,200
| -13% | -$212K |
|
2371
Biglari Holdings Class A
BH.A
$1.24B
| $1.54M | ﹤0.01% |
+1,624
| New | +$1.62M |
|
|
EBIX
2372
DELISTED
Ebix Inc
EBIX
| $1.54M | ﹤0.01% |
20,195
-6,531
| -24% | -$501K |
|
|
GPOR
2373
PUT
DELISTED
Gulfport Energy Corp.
GPOR
| $1.54M | ﹤0.01% |
122,400
| – | – |
|
2374
America's Car Mart
CRMT
$20.4M
| $1.54M | ﹤0.01% |
+24,850
| New | +$1.43M |
|
2375
Coherus Oncology
CHRS
$212M
| $1.53M | ﹤0.01% |
109,183
+94,042
| +621% | +$1.35M |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.